Cargando…
A153 PYCRL LACTYLATION AS A POTENTIAL REGULATOR OF CANCER STEM CELL METABOLISM IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
BACKGROUND: Patients with esophageal malignancy have a 5-year survival rate of only 14% in Canada. This high mortality rate is due to three factors: late diagnosis, difficulty in surgically removing the tumor because of its localization, and treatment resistance. Resistance can be developed after pr...
Autores principales: | Douchin, J, Nogueira de Almeida, L G, Gonneaud, A, Boisvert, F -M, Dufour, A, Giroux, V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991381/ http://dx.doi.org/10.1093/jcag/gwac036.153 |
Ejemplares similares
-
A3 TARGETING PROLINE METABOLISM TO OVERCOME TREATMENT RESISTANCE IN ESOPHAGEAL CANCER
por: Douchin, J, et al.
Publicado: (2022) -
A16 ESOPHAGEAL ORGANOID PROLIFERATION AND DIFFERENTIATION ARE ALTERED BY LOSS OF MSH2
por: Rolland, M, et al.
Publicado: (2022) -
MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6
por: Wei, Lei, et al.
Publicado: (2020) -
ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma
por: Tungekar, Asna, et al.
Publicado: (2018) -
Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells
por: Chen, Chuangui, et al.
Publicado: (2017)